Chlamydia pneumoniae-Mediated Inflammation in Atherosclerosis: A Meta-Analysis

Chlamydia pneumoniae-Mediated Inflammation in Atherosclerosis: A Meta-Analysis

Several studies have attempted to relate the C. pneumoniae-mediated inflammatory state with atherosclerotic cardiovascular diseases, providing inconsistent results. Therefore, we performed a meta-analysis to clarify whether C. pneumoniae may contribute to the pathogenesis of atherosclerosis by enhan...

Full description

Saved in:

Bibliographic Details
Main Authors:	Simone Filardo, Marisa Di Pietro, Alessio Farcomeni, Giovanna Schiavoni, Rosa Sessa
Format:	Article
Language:	English
Published:	Wiley 2015-01-01
Series:	Mediators of Inflammation
Online Access:	http://dx.doi.org/10.1155/2015/378658
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Biofilm in Genital Ecosystem: A Potential Risk Factor for Chlamydia trachomatis Infection
by: Simone Filardo, et al.
Published: (2019-01-01)

Chlamydia Pneumoniae Pneumonia: An Evolving Clinical Spectrum
by: David Megran, et al.
Published: (1995-01-01)

Laboratory Diagnosis of Chlamydia Pneumoniae Infections
by: Rosanna W Peeling
Published: (1995-01-01)

Acute Glomerulonephritis in a Child with Chlamydia pneumoniae Infection: A Case Report
by: Giovanna Vitaliti, et al.
Published: (2013-01-01)

A Case Report of Chlamydia psittaci Infective Endocarditis Complicated With Pneumonia
by: Dongmei Zhao, et al.
Published: (2025-01-01)

Flavonoid Naringenin: A Potential Immunomodulator for Chlamydia trachomatis Inflammation
by: Abebayehu N. Yilma, et al.
Published: (2013-01-01)

Chlamydia pneumoniae Antibodies and C-Reactive Protein Levels in Patients with Abdominal Aortic Aneurysms
by: M. A. Sharif, et al.
Published: (2013-01-01)

Roquefort Cheese Proteins Inhibit Chlamydia pneumoniae Propagation and LPS-Induced Leukocyte Migration
by: Ivan M. Petyaev, et al.
Published: (2013-01-01)

Identification of Sphingomyelinase on the Surface of Chlamydia pneumoniae: Possible Role in the Entry into Its Host Cells
by: Tuula A. Peñate Medina, et al.
Published: (2014-01-01)

The association between Chlamydia pneumoniae infection and prognosis in lung cancer patients: a prospective study
by: Maolin Liu, et al.
Published: (2025-01-01)

Development of an sRNA-mediated conditional knockdown system for Chlamydia trachomatis
by: Janina Ehses, et al.
Published: (2025-02-01)

Galectin-3 Is a Potential Mediator for Atherosclerosis
by: Ziyu Gao, et al.
Published: (2020-01-01)

CD40 in Clinical Inflammation: From Multiple Sclerosis to Atherosclerosis
by: Jon D. Laman, et al.
Published: (1998-01-01)

Association of Plasma Circulatory Markers, Chlamydia pneumoniae, and High Sensitive C-Reactive Protein in Coronary Artery Disease Patients of India
by: Hem Chandra Jha, et al.
Published: (2009-01-01)

The laboratory diagnosis of Chlamydia trachomatis infections
by: Max A Chernesky
Published: (2005-01-01)

C-Peptide: A New Mediator of Atherosclerosis in Diabetes
by: Dusica Vasic, et al.
Published: (2012-01-01)

Profile of Chlamydia vaccine research: A bibliometric analysis
by: Xuemei Wang, et al.
Published: (2025-12-01)

Markers of Inflammation Associated with Plaque Progression and Instability in Patients with Carotid Atherosclerosis
by: Enrico Ammirati, et al.
Published: (2015-01-01)

GLOBAL PREVALENCE OF CHLAMYDIA INFECTION AMONG WILD BIRDS AS PUBLIC HEALTH CONCERNS: A SYSTEMATIC REVIEW AND META-ANALYSIS
by: T. I. Mamun, et al.
Published: (2025-03-01)

The Protective Effect of Naringenin on Airway Remodeling after Mycoplasma Pneumoniae Infection by Inhibiting Autophagy-Mediated Lung Inflammation and Fibrosis
by: Yan Lin, et al.
Published: (2018-01-01)

Vision for Mediators of Inflammation
by: Anshu Agrawal
Published: (2020-01-01)

Mechanistic relationship between obesity-induced inflammation triggering endothelial dysfunction and the initiation of atherosclerosis development
by: Richard L. Jayaraj, et al.
Published: (2025-01-01)

Chlamydia trachomatis Mimicking COVID-19 Chronic Follicular Conjunctivitis
by: Sukhmandeep Kaur, et al.
Published: (2021-01-01)

Risk of Coinfection with Chlamydia trachomatis and Neisseria Gonorrhoeae in Nova Scotia
by: Kevin R Forward
Published: (2010-01-01)

Transforming Growth Factor-β Protects against Inflammation-Related Atherosclerosis in South African CKD Patients
by: Muzamil Olamide Hassan, et al.
Published: (2018-01-01)

Role of CFT and PCR in diagnosis of Chlamydia psittaci in experimentally infected rabbits
by: V. V. Evstifeev, et al.
Published: (2023-09-01)

Impact of a potential Chlamydia vaccine in the USA: mathematical modelling analyses
by: Hiam Chemaitelly, et al.
Published: (2024-05-01)

Sphingolipid metabolites involved in the pathogenesis of atherosclerosis: perspectives on sphingolipids in atherosclerosis
by: Fufangyu Zhao, et al.
Published: (2025-02-01)

Mediators of Inflammation: Inflammation in Cancer, Chronic Diseases, and Wound Healing
by: Caigan Du, et al.
Published: (2015-01-01)

Cecropin AD ameliorates pneumonia and intestinal injury in mice with mycoplasma pneumoniae by mediating gut microbiota
by: Bowen Li, et al.
Published: (2025-01-01)

The Anti-Inflammatory Cytokine, Interleukin-10, Inhibits Inflammatory Mediators in Human Epithelial Cells and Mouse Macrophages Exposed to Live and UV-Inactivated Chlamydia trachomatis
by: Abebayehu N. Yilma, et al.
Published: (2012-01-01)

Golden Tandem of Photothermal Ablation and Simultaneous Anti-Inflammation in One Nanoparticle for Activated Macrophage-Targeted Atherosclerosis Treatment
by: Lu Y, et al.
Published: (2025-02-01)

Level of systemic inflammation markers and clinical course in patients with stable ischemic heart disease with and without coronary atherosclerosis
by: V.I. Tseluyko, et al.
Published: (2021-10-01)

Obstructive Sleep Apnea, Hypertension, and Their Additive Effects on Atherosclerosis
by: Mario Francesco Damiani, et al.
Published: (2015-01-01)

Systematic optimization and evaluation of a Dutch sexual health intervention: Role model stories for chlamydia prevention, testing, and treatment
by: Gido Metz, et al.
Published: (2025-01-01)

Cost Effectiveness Analysis of Azithromycin and Doxycycline for Chlamydia Trachomatis Infection in Women: A Canadian Perspective
by: Fawziah Marra, et al.
Published: (1997-01-01)

Mediators of Gut Mucosal Immunity and Inflammation
by: Ishak Ozel Tekin, et al.
Published: (2015-01-01)

Mediators of Interorgan Crosstalk in Metabolic Inflammation
by: Massimo Collino, et al.
Published: (2013-01-01)

CCR2 signaling regulates anti-chlamydia T cell immune responses in the airway.
by: Shuaini Yang, et al.
Published: (2025-02-01)

Molecular Detection and Genotyping of Chlamydia psittaci in Captive Psittacines from Costa Rica
by: Jessica Sheleby-Elías, et al.
Published: (2013-01-01)